These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3175045)

  • 1. Prognostic significance of estrogen receptor determination in primary breast cancer.
    Ciatto S; Palli D; Iossa A; Pacini P; Cataliotti L; Distante V; Teglia C; Caridi G; Messeri G
    Radiother Oncol; 1988 Jul; 12(3):187-92. PubMed ID: 3175045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of estrogen receptor determination in breast cancer.
    Ciatto S; Bravetti P; Cardona G; Cataliotti L; Crescioli R; Herd-Smith A; Messeri G
    Tumori; 1983 Dec; 69(6):527-30. PubMed ID: 6665875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
    Chevallier B; Heintzmann F; Mosseri V; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M; Asselain B
    Cancer; 1988 Dec; 62(12):2517-24. PubMed ID: 3191451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival with breast cancer: the importance of estrogen receptor quantity.
    Shek LL; Godolphin W
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):243-50. PubMed ID: 2702979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patients.
    Crowe JP; Gordon NH; Hubay CA; Pearson OH; Marshall JS; McGuire WL
    Surgery; 1986 Oct; 100(4):599-605. PubMed ID: 3764686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptors in primary breast cancer.
    Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
    Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of estrogen receptors on survival and recurrence in patients with breast cancer without lymph node metastases.
    Maki HS; Hoehn JL
    Arch Surg; 1989 Mar; 124(3):377-80. PubMed ID: 2919970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant hormone treatment and chemotherapy in postmenopausal women with operable breast cancer: a retrospective analysis.
    Oriana S; Coradini D; Sasso GM; Di Fronzo G
    Anticancer Res; 1991; 11(6):2199-205. PubMed ID: 1776861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor level and other factors in early recurrence of breast cancer.
    Westerberg H; Gustafson SA; Nordenskjöld B; Silfverswärd C; Wallgren A
    Int J Cancer; 1980 Oct; 26(4):429-33. PubMed ID: 7251221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
    Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
    Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Cancer; 1988 Jun; 61(11):2168-75. PubMed ID: 3130175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E; Paszko Z; Mazur S
    Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol receptor activity in human breast cancer, disease free interval and survival time.
    Heise E; Görlich M
    Anticancer Res; 1982; 2(1-2):33-6. PubMed ID: 7114801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer.
    Bertuzzi A; Daidone MG; Di Fronzo G; Silvestrini R
    Breast Cancer Res Treat; 1981; 1(3):253-62. PubMed ID: 7348575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.